|
Investor Relations
Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.
Recent ReleasesJan 4, 2012 Dec 9, 2011 |
|
||||||||||||||||||||
|
 |
 |
| Exact Sciences Corporation | 441 Charmany Drive | Madison, WI 53719 | Tel: 608.284.5700 | Fax: 608.284.5701 |
|
|
|
| home | about us | about colorectal cancer | the exact sciences solution | investor relations | contact us |
|
| Certain statements contained in this website, other than historical information, consist of forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not guarantees of future performance and are subject to a variety of risks and uncertainties that could cause actual results to differ materially from the results contemplated thereby. Any forward-looking statements we make should be considered in light of the risks and uncertainties described in our filings with the Securities and Exchange Commission, including but not limited to those described in our most recent Form 10-K and subsequent Forms 10-Q. We undertake no obligation to update or revise the information provided herein, whether as the result of new information, future events or circumstances or otherwise. |
|
| Site design and layout by bfw Advertising |